Nephros Stock Gross Profit
| NEPH Stock | USD 2.19 0.05 2.34% |
Nephros fundamentals help investors to digest information that contributes to Nephros' financial success or failures. It also enables traders to predict the movement of Nephros Stock. The fundamental analysis module provides a way to measure Nephros' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nephros stock.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 8.2 M | 8.6 M | |
| Gross Profit Margin | 0.58 | 0.34 |
Nephros | Gross Profit |
Nephros Company Gross Profit Analysis
Nephros' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Nephros Gross Profit | 4.73 M |
Most of Nephros' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nephros is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Nephros Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Nephros is extremely important. It helps to project a fair market value of Nephros Stock properly, considering its historical fundamentals such as Gross Profit. Since Nephros' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nephros' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nephros' interrelated accounts and indicators.
Click cells to compare fundamentals
Nephros Gross Profit Historical Pattern
Today, most investors in Nephros Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nephros' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's gross profit growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nephros gross profit as a starting point in their analysis.
Nephros Gross Profit |
| Timeline |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Nephros reported 4.73 M of gross profit. This is 99.79% lower than that of the Household Durables sector and 99.49% lower than that of the Consumer Discretionary industry. The gross profit for all United States stocks is 99.98% higher than that of the company.
Nephros Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nephros' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nephros could also be used in its relative valuation, which is a method of valuing Nephros by comparing valuation metrics of similar companies.Nephros is currently under evaluation in gross profit category among related companies.
Nephros Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nephros from analyzing Nephros' financial statements. These drivers represent accounts that assess Nephros' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nephros' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 35.1M | 75.0M | 77.9M | 11.9M | 35.9M | 20.2M | |
| Enterprise Value | 32.6M | 73.4M | 71.8M | 9.4M | 33.5M | 18.9M |
Nephros Fundamentals
| Return On Equity | -0.18 | |||
| Return On Asset | -0.0871 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 20.09 M | |||
| Shares Outstanding | 10.54 M | |||
| Shares Owned By Insiders | 11.96 % | |||
| Shares Owned By Institutions | 40.28 % | |||
| Number Of Shares Shorted | 2.56 K | |||
| Price To Earning | (4.51) X | |||
| Price To Book | 2.52 X | |||
| Price To Sales | 1.48 X | |||
| Revenue | 14.24 M | |||
| Gross Profit | 4.73 M | |||
| EBITDA | (1.38 M) | |||
| Net Income | (1.57 M) | |||
| Cash And Equivalents | 4.18 M | |||
| Cash Per Share | 0.41 X | |||
| Total Debt | 1.84 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 5.27 X | |||
| Book Value Per Share | 0.79 X | |||
| Cash Flow From Operations | 827 K | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | (0.15) X | |||
| Target Price | 4.75 | |||
| Number Of Employees | 31 | |||
| Beta | 1.26 | |||
| Market Capitalization | 22.56 M | |||
| Total Asset | 11.86 M | |||
| Retained Earnings | (144.41 M) | |||
| Working Capital | 6.29 M | |||
| Current Asset | 1.53 M | |||
| Current Liabilities | 684 K | |||
| Net Asset | 11.86 M |
About Nephros Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nephros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nephros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nephros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nephros Piotroski F Score and Nephros Altman Z Score analysis. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Nephros Stock analysis
When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 1.371 | Quarterly Revenue Growth 0.272 | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.